AI Summary
Summary: Scientists have identified a new drug target for Respiratory Syncytial Virus (RSV) by determining how the virus evades the immune response. This discovery could lead to the development of new treatments for RSV.
Scientists have discovered how the dangerous Respiratory Syncytial Virus (RSV) defuses our immune response and, in doing so, they have pinpointed an exciting new target for drug developers.